Clinical Trials in Baltimore

Showing 5841-5860 of 23,476 trials

Epidiolex® for Anxiety in Pediatric Epilepsy

NCT05324449

This is a prospective open label study assessing the efficacy and tolerability of pharmaceutical grade cannabidiol--Epidiolex (R), for the treatment of anxiety in pediatric patients with pediatric epilepsy that has been difficult to treat and requires ongoing use of anticonvulsant medication.

AnxietyEpilepsy

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.20 participantsStarted Apr 2022

Baltimore, Maryland, United States

Active Not RecruitingPhase 2< 1 mile

Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer

NCT01937117

This research is being done to determine if early changes on a type of imaging procedure called PET (Positron Emission Tomography) can predict which patients are most likely to respond to the combination of trastuzumab and pertuzumab when given prior to surgery.

Breast Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins88 participantsStarted Jan 2014

Birmingham, Alabama, United States • Washington D.C., District of Columbia, United States • Indianapolis, Indiana, United States +7 more locations

Epidiolex® for Anxiety in Pediatric Epilepsy

Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer

Find Trials by Condition in Baltimore

Drug-Drug Interaction Potential of Mavorixafor

Proton Radiation Therapy Registry

1911GCCC: Galeterone With Gemcitabine for Patients With Metastatic Pancreatic Adenocarcinoma

Impact of Itraconazole on the Pharmacokinetics and Safety of Dazucorilant in Healthy, Adult Participants

Vaginal Ecosystem and Network in the United States Study

Growth Hormone in a Patient With a Dominant-Negative GHR Mutation

Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 1)

Clinical Evaluation of an Augmented Reality Intraprocedural Needle Guidance Platform for Soft Tissue Biopsy

Plant-Based Dietary Intervention in Type 2 Diabetes-2

Propranolol Hydrochloride and Pembrolizumab in Treating Patients With Stage IIIC-IV Melanoma That Cannot Be Removed by Surgery

A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma

DAYBREAK: A Study of Setmelanotide in Participants With Specific Gene Variants in the Melanocortin-4 Receptor (MC4R) Pathway

TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers

Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma

Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates

BNT151 as a Monotherapy and in Combination With Other Anti-cancer Agents in Patients With Solid Tumors

Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)

A Study to Evaluate Guselkumab for the Treatment of Participants With New-onset or Relapsing Giant Cell Arteritis